September 17, 2024
Treatments like GLP-1s are effective, but they're also extremely expensive. With GLP-1s rising in demand, it can pose a challenge for employers trying to offer robust, sustainable benefits to their employees at an affordable cost to the plan and members. Learn how employers can address these rising drug costs.